Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.
Schumann S, Kaiser A, Nicoletti F, Mangano K, Fagone P, van Wijk E, Yan Y, Schulz P, Ludescher B, Niedermaier M, von Wegerer J, Rauch P, Setz C, Schubert U, Brysch W. Schumann S, et al. Among authors: kaiser a. Int J Mol Sci. 2020 Nov 20;21(22):8803. doi: 10.3390/ijms21228803. Int J Mol Sci. 2020. PMID: 33233817 Free PMC article.
Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial.
Sager P, Kaiser A, Schumann S, Ludescher B, Niedermaier M, Schmidt I, Och K, Dings C, Lehr T, Brysch W. Sager P, et al. Among authors: kaiser a. Lancet Reg Health Eur. 2023 Dec 6;37:100810. doi: 10.1016/j.lanepe.2023.100810. eCollection 2024 Feb. Lancet Reg Health Eur. 2023. PMID: 38076629 Free PMC article.
Efficacy of MP1032 in hospitalised patients with COVID-19- authors' reply.
Sager P, Kaiser A, Schumann S, Ludescher B, Brysch W. Sager P, et al. Among authors: kaiser a. Lancet Reg Health Eur. 2024 Feb 2;38:100857. doi: 10.1016/j.lanepe.2024.100857. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328414 Free PMC article. No abstract available.
Final Validation of the Quality of Life after Brain Injury for Children and Adolescents (QOLIBRI-KID/ADO) Questionnaire.
von Steinbuechel N, Zeldovich M, Timmermann D, Krenz U, Koerte IK, Bonfert MV, Berweck S, Kieslich M, Henrich M, Brockmann K, Buchheim A, Roediger M, Lendt M, Auer C, Neu A, Kaiser A, Driemeyer J, Greving S, Wartemann U, Pinggera D, Thomé C, Suss J, Muehlan H, Cunitz K. von Steinbuechel N, et al. Among authors: kaiser a. Children (Basel). 2024 Apr 5;11(4):438. doi: 10.3390/children11040438. Children (Basel). 2024. PMID: 38671655 Free PMC article.
Protocol for the Adolescent Menstrual Experiences and Health Cohort (AMEHC) Study in Khulna, Bangladesh: A Prospective cohort to quantify the influence of menstrual health on adolescent girls' health and education outcomes.
Hennegan J, Hasan MT, Jabbar A, Jalil T, Kennedy E, Hunter E, Kaiser A, Akter S, Zaman A, Rahman MU, Dunstan L, Head A, Scott N, Weiss HA, Win TM, Melendez-Torres GJ, Than KK, Hughes CL, Grover S, Hasan M, Rashid SF, Azzopardi P. Hennegan J, et al. Among authors: kaiser a. BMJ Open. 2024 Apr 10;14(4):e079451. doi: 10.1136/bmjopen-2023-079451. BMJ Open. 2024. PMID: 38604626 Free PMC article.
A toxicology study of Csf2ra complementation and pulmonary macrophage transplantation therapy of hereditary PAP in mice.
Arumugam P, Carey BC, Wikenheiser-Brokamp KA, Krischer J, Wessendarp M, Shima K, Chalk C, Stock J, Ma Y, Black D, Imbrogno M, Collins M, Kalenda Yombo DJ, Sakthivel H, Suzuki T, Lutzko C, Cancelas JA, Adams M, Hoskins E, Lowe-Daniels D, Reeves L, Kaiser A, Trapnell BC. Arumugam P, et al. Among authors: kaiser a. Mol Ther Methods Clin Dev. 2024 Feb 17;32(2):101213. doi: 10.1016/j.omtm.2024.101213. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38596536 Free PMC article.
1,213 results